This inventor holds 40 USPTO granted patents and 7 published patent applications, plus 7 CIPO patents and 17 EPO patents, primarily in Kinase Inhibitors. Top assignees: Astrazeneca Ab, Celgene International Ii Sarl, Receptos, Inc.. Active years: 1999-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Leics, GB (1999)
- Cheshire, GB (2014)
- Leicestershire, GB (2010 - 2015)
- Loughbourough, GB (2017)
- Loughborough, GB (2000 - 2019)
- Nottingham, GB (2016 - 2022)
Company Filing History:
10 out of 1,534 
7 out of 17 
6 out of 25 
Years Active: 1999-2022
Areas of Expertise:
Title: The Innovations of Inventor Premji Meghani
Premji Meghani, an accomplished inventor based in Loughborough, GB, has made significant contributions to the field of pharmaceutical innovation, holding an impressive 40 patents. His work primarily focuses on developing compounds with therapeutic applications, particularly in the area of inflammatory diseases.
Latest Patents
Among his latest inventions, Premji Meghani has developed inhibitors of plasma kallikrein. This invention provides various compounds that can be utilized in therapeutic settings for treating or preventing conditions associated with plasma kallikrein activity. Additionally, he has created kinase inhibitors, which demonstrate anti-inflammatory activity by inhibiting specific kinase enzymes. These compounds hold promise for use in treating a range of inflammatory diseases, including those affecting the lungs, eyes, and intestines.
Career Highlights
Premji Meghani's career includes notable positions at prominent pharmaceutical companies, including AstraZeneca and Topivert Pharma Limited. His expertise in medicinal chemistry and drug development has led to significant advancements in therapies aimed at mitigating inflammatory responses.
Collaborations
Throughout his career, Meghani has collaborated with distinguished colleagues, including Andrew Richard Novak and Marcus F Boehm. These partnerships have enhanced his research capabilities and innovation potential, leading to the creation of several ground-breaking therapeutic solutions.
Conclusion
In summary, inventor Premji Meghani has established himself as a leading figure in pharmaceutical innovation. His extensive patent portfolio and collaborative endeavors exemplify his dedication to advancing the medical field. With ongoing work in inhibitors and kinase compounds, Meghani continues to pave the way for future advancements in therapy and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile